May 2026 – Newly minted neuroscience PhD, Dr. Emily Allgires (Sah lab, left in photo) reports in a first author paper in 'Journal of Neuroinflammation' that "A novel interoceptive subfornical organ to infralimbic cortex mechanism relays airway inflammation effects on fear extinction." Dr. Sah (right in photo), Dr. Andrew Winter (Sah lab alum), Liz Mancz (Sah lab P&P PhD student), Rebecca Ahlbrand (Sah lab), Dr. Wohleb, and Dr. Vollmer (Wohleb lab) also contributed.

May 2026 – Dr. Perez-Tilve and his collaborators report in 'Nature' that "GLP-1R–GIPR–PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice."

May 2026 – Dr. Drosatos and colleagues review the "International Utah cardiac recovery symposium (U-CARS) 2025: translational and basic science proceedings" for "Heart Failure Reviews."

May 2026 – Dr. Perez-Tilve and colleagues report in 'Molecular Metabolism' that "GIPR:GCGR co-agonism restores normal weight in obese rodents."

May 2026 - Dr. Fan and colleagues report in 'JACC: Basic to Translational Science' that "JP2 and JCN crosstalk abrogate MURF1-mediated JCN ubiquitination and degradation in cardiomyocytes."

May 2026 - With her colleagues, Dr. Kranias describes "AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: rationale and study design of the GenePHIT trial" in 'European Journal of Heart Failure'

May 2026 – Dr. Sah (right) and PhD students Liz Mancz (middle) and Taylor Peach (left) review "Neuroimmune regulation of behavior: focus on sensory circumventricular organs and associated cell circuit mechanisms" in 'Journal of Immunology'.

May 2026 - Dr. Gao and colleagues discuss "RNA splicing in human cardiomyopathies: shared landscape in diverse pathogenic paths" in a commentary published in 'Cardiovascular Research.'

May 2026 - Dr. Chella Krishnan and collaborators report on "Cell type-specific control of cardiometabolic disease by the dileucine motif of the LDL receptor-related protein LRP1" in 'Journal of Biological Chemistry.'